SCENAR device applied to a patient’s back for pain management

Effective Treatment of Drug Refractory Functional Dyspepsia Using SCENAR Therapy: A Case Report

8 years ago

Did you know that during our webinars we present SCENAR information in ways people can easily understand. All the PowerPoint/Slideshow presentations are readable and topic relevant. We use clear, simple and concise statements in English that help our audience successfully translate (if needed) the presentation into any foreign language.
We pay close attention to plain language and design of our materials to enhance ease of use for all readers (not the live webinar participants) and word-for-word translations from English into any desired language.
All the techniques discussed during the webinars are shown according to the algorithms of application.

Functional dyspepsia is a complex of symptoms characterized by upper abdominal discomfort or pain, nausea, vomiting, bloating, early satiety, and anorexia. Standard pharmacological treatment often has low efficacy and might cause side effects associated with the drugs. Patients with functional dyspepsia which is refractory to drug treatments require other therapeutic options. We report a case of a 52-year-old female with medically refractory functional dyspepsia which was successfully treated using Self Controlled Energo-Neuro Adaptive Regulator (SCENAR) therapy. The initial effect of the treatment was documented after 2 sessions and a considerable improvement after 4 sessions. The treatment continued for 2 weeks and included 12 sessions after which all the symptoms were eliminated without any adverse reactions. The conditions of the patient were monitored for 12 months and no recurrent symptoms were observed. This case report suggests that the use of SCENAR therapy provides efficient results for treatment of drug-resistant functional dyspepsia leading to a marked improvement of the conditions of the patient. Additional clinical studies are required to further investigate the effectiveness of this treatment method in other patients.

Author: M Gurevich and V Gurevich*